John-Paul Bonansinga MD received his medical degree in May 2022 from University of Texas Health & Science Center in San Antonio. He is the founder of Forge Applied Science & Technology (“F.A.S.T”) and led the rapid development of the company’s flagship point-of-care UV-C sterilization reactor during the first 16 months of the pandemic. The 3rd full engineering cycle for F.A.S.T’s pre-production protype was completed in only 3-months with successful manufacturing and assembly trials following in rapid sequence. He graduated from The University of Texas at Dallas with a BS in Neuroscience in 2016, and conducted undergraduate research in neurodegenerative disorders. Dr. Bonansinga is a combat veteran who was assigned to 1st Battalion, 75th Ranger Regiment from 2004 to 2008. He deployed extensively as a Foreign Service Officer in support of Department of Defense missions between 2009 and 2017.
Dr. Bonansinga conducted a comprehensive survey of MDI projects in Fall 2022 to identify medical, material, design, and sterile processing considerations for future technology transition and commercialization efforts. He is currently engaged in independent research projects, but regularly allocates time to assist MDI teams.